$LLY · Eli Lilly and Company

This filing is an amended Schedule 13G submitted by Lilly Endowment, Inc., an Indiana nonprofit private foundation, concerning its ownership of Eli Lilly and Company common stock. The report is dated October 19, 2026, and states the endowment’s holdings as of September 30, 2026.

According to the filing, Lilly Endowment beneficially owns 90,066,978 shares of Eli Lilly common stock, representing 9.6 percent of the class. That percentage is based on 941,357,065 shares outstanding as of August 3, 2026, as reported in Eli Lilly’s Form 10-Q for the period ended June 30, 2026. The endowment reports having sole power to vote and dispose of all 90,066,978 shares, with no shared voting or dispositive power.

This is the 47th amendment to the endowment’s Schedule 13G, updating its ownership disclosure under securities regulations. The filing identifies Lilly Endowment as the reporting person and does not list any other holders or group members.